Peter Niehoff
Overview
Explore the profile of Peter Niehoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
49
Citations
1141
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
22.
Polgar C, Ott O, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al.
Lancet Oncol
. 2017 Jan;
18(2):259-268.
PMID: 28094198
Background: We previously confirmed the non-inferiority of accelerated partial breast irradiation (APBI) with interstitial brachytherapy in terms of local control and overall survival compared with whole-breast irradiation for patients with...
23.
Tagliaferri L, Kovacs G, Autorino R, Budrukkar A, Guinot J, Hildebrand G, et al.
J Contemp Brachytherapy
. 2016 Sep;
8(4):336-43.
PMID: 27648088
Purpose: Aim of the COBRA (Consortium for Brachytherapy Data Analysis) project is to create a multicenter group (consortium) and a web-based system for standardized data collection. Material And Methods: GEC-ESTRO...
24.
Ott O, Strnad V, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al.
Radiother Oncol
. 2016 Jul;
120(1):119-23.
PMID: 27422584
Background And Purpose: To compare early side effects and patient compliance of accelerated partial breast irradiation (APBI) with multicatheter brachytherapy to external beam whole breast irradiation (WBI) in a low-risk...
25.
Jiang P, Baumann R, Dunst J, Geenen M, Siebert F, Niehoff P, et al.
Int J Radiat Oncol Biol Phys
. 2016 Feb;
94(3):532-6.
PMID: 26867882
Purpose: To prospectively evaluate high-dose-rate brachytherapy in the treatment of therapy-resistant keloids and report first results, with emphasis on feasibility and early treatment outcome. Methods And Materials: From 2009 to...
26.
Strnad V, Ott O, Hildebrandt G, Kauer-Dorner D, Knauerhase H, Major T, et al.
Lancet
. 2015 Oct;
387(10015):229-38.
PMID: 26494415
Background: In a phase 3, randomised, non-inferiority trial, accelerated partial breast irradiation (APBI) for patients with stage 0, I, and IIA breast cancer who underwent breast-conserving treatment was compared with...
27.
Major T, Gutierrez C, Guix B, Mozsa E, Hannoun-Levi J, Lossl K, et al.
Brachytherapy
. 2015 Jul;
14(6):925-32.
PMID: 26209477
Purpose: To investigate interobserver variations of target volume delineations in accelerated partial breast irradiation with multicatheter brachytherapy (BT) and to assess the impact of guidelines on consistency of contouring. Methods...
28.
Niehoff P, Kovacs G
J Gastrointest Oncol
. 2014 Jul;
5(3):218-22.
PMID: 24982770
The challenge of treating anal cancer is to preserve the anal sphincter function while giving high doses to the tumor and sparing the organ at risk. For that reason there...
29.
Roth A, Kauer-Dorner D, Resch A, Schmid A, Thill M, Niehoff P, et al.
Brachytherapy
. 2014 Jun;
13(4):394-9.
PMID: 24946973
Purpose: To evaluate accelerated partial breast irradiation (APBI) in patients after oncoplastic surgery for early breast cancer. Methods And Materials: A retrospective analysis of 136 breasts of 134 patients, who...
30.
Salembier C, Rijnders A, Henry A, Niehoff P, Siebert F, Hoskin P
J Contemp Brachytherapy
. 2013 Jul;
5(2):63-9.
PMID: 23878549
Purpose: To evaluate in a multicenter setting the ability of centers to perform pre-implant permanent prostate brachytherapy planning, fulfilling dosimetric goals and constraints based on the Groupe de Curiethérapie-European Society...